These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 24778067)
1. Number of extraspinal organs with metastases: a prognostic factor of survival in patients with metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC). Rades D; Weber A; Karstens JH; Schild SE; Bartscht T Anticancer Res; 2014 May; 34(5):2503-7. PubMed ID: 24778067 [TBL] [Abstract][Full Text] [Related]
2. Prognostic role of the number of involved extraspinal organs in patients with metastatic spinal cord compression. Rades D; Weber A; Karstens JH; Schild SE; Bartscht T Clin Neurol Neurosurg; 2014 Mar; 118():12-5. PubMed ID: 24529222 [TBL] [Abstract][Full Text] [Related]
3. Survival in patients with metastatic spinal cord compression from prostate cancer is associated with the number of extra-spinal organs involved. Weber A; Bartscht T; Karstens JH; Schild SE; Rades D Anticancer Res; 2013 Oct; 33(10):4505-7. PubMed ID: 24123022 [TBL] [Abstract][Full Text] [Related]
4. Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication. Park SJ; Lee CS; Chung SS Spine J; 2016 Mar; 16(3):322-8. PubMed ID: 26586194 [TBL] [Abstract][Full Text] [Related]
6. Prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression from non-small cell lung cancer. Lei M; Liu Y; Tang C; Yang S; Liu S; Zhou S BMC Cancer; 2015 Nov; 15():853. PubMed ID: 26541141 [TBL] [Abstract][Full Text] [Related]
7. Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients. Rades D; Douglas S; Veninga T; Bajrovic A; Stalpers LJ; Hoskin PJ; Rudat V; Schild SE Strahlenther Onkol; 2012 Jun; 188(6):472-6. PubMed ID: 22361746 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer patients with metastatic spinal cord compression. Number of extraspinal organs involved by metastases influences survival. Weber A; Bartscht T; Karstens JH; Schild SE; Rades D Strahlenther Onkol; 2014 Mar; 190(3):283-6. PubMed ID: 24264465 [TBL] [Abstract][Full Text] [Related]
9. Impact of Symptomatic Metastatic Spinal Cord Compression on Survival of Patients with Non-Small-Cell Lung Cancer. da Silva GT; Bergmann A; Thuler LCS World Neurosurg; 2017 Dec; 108():698-704. PubMed ID: 28951180 [TBL] [Abstract][Full Text] [Related]
10. A new prognostic factor for the survival of patients with renal cell carcinoma developing metastatic spinal cord compression. Rades D; Weber A; Bartscht T; Bajrovic A; Karstens JH; Schild SE Strahlenther Onkol; 2014 Jul; 190(7):667-70. PubMed ID: 24535650 [TBL] [Abstract][Full Text] [Related]
11. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary. Rades D; Fehlauer F; Veninga T; Stalpers LJ; Basic H; Hoskin PJ; Rudat V; Karstens JH; Schild SE; Dunst J Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):532-7. PubMed ID: 17084539 [TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. Rades D; Fehlauer F; Schulte R; Veninga T; Stalpers LJ; Basic H; Bajrovic A; Hoskin PJ; Tribius S; Wildfang I; Rudat V; Engenhart-Cabilic R; Karstens JH; Alberti W; Dunst J; Schild SE J Clin Oncol; 2006 Jul; 24(21):3388-93. PubMed ID: 16849752 [TBL] [Abstract][Full Text] [Related]
13. Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer. Rades D; Motisi L; Veninga T; Conde-Moreno A; Cacicedo J; Schild SE Clin Lung Cancer; 2019 Jul; 20(4):322-329. PubMed ID: 31155476 [TBL] [Abstract][Full Text] [Related]
14. A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses. Rades D; Huttenlocher S; Veninga T; Bajrovic A; Bremer M; Rudat V; Schild SE Radiat Oncol; 2015 Apr; 10():90. PubMed ID: 25889036 [TBL] [Abstract][Full Text] [Related]
15. A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression. Rades D; Rudat V; Veninga T; Stalpers LJ; Basic H; Karstens JH; Hoskin PJ; Schild SE Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):905-8. PubMed ID: 18436390 [TBL] [Abstract][Full Text] [Related]
16. A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study. Rades D; Fehlauer F; Stalpers LJ; Wildfang I; Zschenker O; Schild SE; Schmoll HJ; Karstens JH; Alberti W Cancer; 2004 Dec; 101(11):2687-92. PubMed ID: 15493037 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer. Rades D; Stalpers LJ; Veninga T; Rudat V; Schulte R; Hoskin PJ J Urol; 2006 Feb; 175(2):552-6. PubMed ID: 16406994 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression. Rades D; Rudat V; Veninga T; Stalpers LJ; Hoskin PJ; Schild SE Cancer; 2008 Sep; 113(5):1090-6. PubMed ID: 18642349 [TBL] [Abstract][Full Text] [Related]